Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity

The study concerns patients who have been treated for breast cancer, have cognitive problems and are planning to return to work or are currently working and wish to begin cognitive rehabilitation.

Patients will follow the Virtual Reality program developed for the study, during the cognitive rehabilitation usually proposed in the establishment, at the rate of a weekly session of 10-15 minute for 6 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Cancer-related Cognitive Difficulties Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Centre François Baclesse

Caen, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients >18 years of age
Patient with breast cancer for whom adjuvant chemotherapy has been administered; maintenance treatments (e.g. Trastuzumab, hormone therapy) are eligible,
Maximum 2 years after completion of adjuvant treatment,
Patients who have cognitive complaints at inclusion (answer yes to the question: 'Since your cancer treatment, have you had any difficulties with memory, concentration, etc.?)
Patients planning to return to work or who have returned to work in the past year,
Signature of informed consent prior to any specific procedure relating to the study,
Patient affiliated to a social security system.

Exclusion criteria

Patients suffering from illnesses or conditions that impair their ability to understand, follow and/or comply with study procedures,
Patients with personality disorders and/or psychiatric pathology,
Patients deprived of their liberty or placed under the authority of a guardian,
Pregnant women

Treatment and study plan

Virtual Reality sessions

Behavioral

One session during 10-15 minutes per week for 6 weeks.

Primary outcomes

Proportion of patients adhering to the Virtual Reality program

Time frame: At 6 weeks

Adherence is defined as the completion of at least 5 of the 6 sessions planned.

Sponsors and collaborators

Lead sponsor

Centre Francois Baclesse

Other

Registry information

Acronym: Cog-RV

Important dates

Study start: 2024
Primary completion: 2026
Study completion: 2026
First posted: Feb 20, 2024
Registry last updated: Feb 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Terminated